The International Association for the Study of Pain recently released a statement on the strength of current research on cannabis and cannabinoid use in pain management. What did they find?
A new study on conversion of acute to chronic low back pain identifies clinician behavior as well as patient characteristics that increase that risk.
New and highly specific migraine drugs have significantly changed the clinical landscape for patients. We talked with Peter McAllister, MD, about where the research goes next.